Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 3757 to 3761 of 3761 entries
Sorted by: Best Match Show Resources per page
Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy.

Scientific reports

Iizuka Y, Katagiri T, Inoue M, Nakamura K, Mizowaki T.
PMID: 34750482
Sci Rep. 2021 Nov 08;11(1):21858. doi: 10.1038/s41598-021-01432-x.

This study aimed to evaluate the feasibility of quantifying iodine-131 (

Cite
Iizuka Y, Katagiri T, Inoue M, et al. Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy. Sci Rep. 2021;11(1):21858doi: 10.1038/s41598-021-01432-x.
Iizuka, Y., Katagiri, T., Inoue, M., Nakamura, K., & Mizowaki, T. (2021). Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy. Scientific reports, 11(1), 21858. https://doi.org/10.1038/s41598-021-01432-x
Iizuka, Yusuke, et al. "Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy." Scientific reports vol. 11,1 (2021): 21858. doi: https://doi.org/10.1038/s41598-021-01432-x
Iizuka Y, Katagiri T, Inoue M, Nakamura K, Mizowaki T. Comparison between planar and single-photon computed tomography images for radiation intensity quantification in iodine-131 scintigraphy. Sci Rep. 2021 Nov 08;11(1):21858. doi: 10.1038/s41598-021-01432-x. PMID: 34750482; PMCID: PMC8576011.
Copy Download .nbib Format: NLM
Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study.

Japanese journal of radiology

Ashida R, Nakamura K, Aizawa R, Iramina H, Takayama K, Nakamura M, Mizowaki T.
PMID: 34350542
Jpn J Radiol. 2021 Aug 05; doi: 10.1007/s11604-021-01186-6. Epub 2021 Aug 05.

PURPOSE: The purpose of this planning study was to develop an acceptable technique for highly hypofractionated intensity-modulated radiation therapy using simultaneous integrated boost technique (SIB-hHF-RT) for nonmetastatic National Comprehensive Cancer Network high-risk prostate cancer.MATERIALS AND METHODS: We created SIB-hHF-RT...

Cite
Ashida R, Nakamura K, Aizawa R, et al. Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study. Jpn J Radiol. 2021;doi: 10.1007/s11604-021-01186-6.
Ashida, R., Nakamura, K., Aizawa, R., Iramina, H., Takayama, K., Nakamura, M., & Mizowaki, T. (2021). Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study. Japanese journal of radiology, . https://doi.org/10.1007/s11604-021-01186-6
Ashida, Ryo, et al. "Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study." Japanese journal of radiology vol. (2021). doi: https://doi.org/10.1007/s11604-021-01186-6
Ashida R, Nakamura K, Aizawa R, Iramina H, Takayama K, Nakamura M, Mizowaki T. Highly hypofractionated intensity-modulated radiation therapy for nonmetastatic prostate cancer with a simultaneous integrated boost to intraprostatic lesions: a planning study. Jpn J Radiol. 2021 Aug 05; doi: 10.1007/s11604-021-01186-6. Epub 2021 Aug 05. PMID: 34350542.
Copy Download .nbib Format: NLM
Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma.

HPB : the official journal of the International Hepato Pancreato Biliary Association

Yamada T, Nakanishi Y, Hayashi H, Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S, Shichinohe T, Mitsuhashi T, Hirano S.
PMID: 34903468
HPB (Oxford). 2021 Nov 25; doi: 10.1016/j.hpb.2021.11.008. Epub 2021 Nov 25.

BACKGROUND: Lymph node metastasis (LNM) is one of the most adverse prognostic factors in extrahepatic cholangiocarcinoma (EHCC) cases. As next-generation sequencing technology has become more widely available, the genomic profile of biliary tract carcinoma has been clarified. However, whether...

Cite
Yamada T, Nakanishi Y, Hayashi H, et al. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB (Oxford). 2021;doi: 10.1016/j.hpb.2021.11.008.
Yamada, T., Nakanishi, Y., Hayashi, H., Tanishima, S., Mori, R., Fujii, K., Okamura, K., Tsuchikawa, T., Nakamura, T., Noji, T., Asano, T., Matsui, A., Tanaka, K., Watanabe, Y., Kurashima, Y., Ebihara, Y., Murakami, S., Shichinohe, T., Mitsuhashi, T., & Hirano, S. (2021). Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB : the official journal of the International Hepato Pancreato Biliary Association, . https://doi.org/10.1016/j.hpb.2021.11.008
Yamada, Toru, et al. "Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma." HPB : the official journal of the International Hepato Pancreato Biliary Association vol. (2021). doi: https://doi.org/10.1016/j.hpb.2021.11.008
Yamada T, Nakanishi Y, Hayashi H, Tanishima S, Mori R, Fujii K, Okamura K, Tsuchikawa T, Nakamura T, Noji T, Asano T, Matsui A, Tanaka K, Watanabe Y, Kurashima Y, Ebihara Y, Murakami S, Shichinohe T, Mitsuhashi T, Hirano S. Targeted amplicon sequencing for primary tumors and matched lymph node metastases in patients with extrahepatic cholangiocarcinoma. HPB (Oxford). 2021 Nov 25; doi: 10.1016/j.hpb.2021.11.008. Epub 2021 Nov 25. PMID: 34903468.
Copy Download .nbib Format: NLM
Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis.

Nephron

Imamura K, Yamamoto S, Suzuki Y, Matsuzawa R, Harada M, Yoshikoshi S, Yoshida A, Matsunaga A.
PMID: 34535597
Nephron. 2021 Sep 14;1-8. doi: 10.1159/000518810. Epub 2021 Sep 14.

INTRODUCTION: There are limited screening tools for sarcopenia in patients undergoing hemodialysis. This study aimed to investigate the reliability and validity of the SARC-F (Strength, Assistance in walking, Rise from a chair, Climb stairs, and Falls) questionnaire as a...

Cite
Imamura K, Yamamoto S, Suzuki Y, et al. Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron. 2021;1-8doi: 10.1159/000518810.
Imamura, K., Yamamoto, S., Suzuki, Y., Matsuzawa, R., Harada, M., Yoshikoshi, S., Yoshida, A., & Matsunaga, A. (2021). Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron, 1-8. https://doi.org/10.1159/000518810
Imamura, Keigo, et al. "Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis." Nephron vol. (2021): 1-8. doi: https://doi.org/10.1159/000518810
Imamura K, Yamamoto S, Suzuki Y, Matsuzawa R, Harada M, Yoshikoshi S, Yoshida A, Matsunaga A. Limitations of SARC-F as a Screening Tool for Sarcopenia in Patients on Hemodialysis. Nephron. 2021 Sep 14;1-8. doi: 10.1159/000518810. Epub 2021 Sep 14. PMID: 34535597.
Copy Download .nbib Format: NLM
Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injury.

Scientific reports

Soranno DE, Baker P, Kirkbride-Romeo L, Wennersten SA, Ding K, Keith B, Cavasin MA, Altmann C, Bagchi RA, Haefner KR, Montford J, Gist KM, Vergnes L, Reue K, He Z, Elajaili H, Okamura K, Nozik E, McKinsey TA, Faubel S.
PMID: 35022484
Sci Rep. 2022 Jan 12;12(1):643. doi: 10.1038/s41598-021-04701-x.

Acute kidney injury (AKI) is common in patients, causes systemic sequelae, and predisposes patients to long-term cardiovascular disease. To date, studies of the effects of AKI on cardiovascular outcomes have only been performed in male mice. We recently demonstrated...

Cite
Soranno DE, Baker P, Kirkbride-Romeo L, et al. Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injury. Sci Rep. 2022;12(1):643doi: 10.1038/s41598-021-04701-x.
Soranno, D. E., Baker, P., Kirkbride-Romeo, L., Wennersten, S. A., Ding, K., Keith, B., Cavasin, M. A., Altmann, C., Bagchi, R. A., Haefner, K. R., Montford, J., Gist, K. M., Vergnes, L., Reue, K., He, Z., Elajaili, H., Okamura, K., Nozik, E., McKinsey, T. A., & Faubel, S. (2022). Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injury. Scientific reports, 12(1), 643. https://doi.org/10.1038/s41598-021-04701-x
Soranno, Danielle E, et al. "Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injury." Scientific reports vol. 12,1 (2022): 643. doi: https://doi.org/10.1038/s41598-021-04701-x
Soranno DE, Baker P, Kirkbride-Romeo L, Wennersten SA, Ding K, Keith B, Cavasin MA, Altmann C, Bagchi RA, Haefner KR, Montford J, Gist KM, Vergnes L, Reue K, He Z, Elajaili H, Okamura K, Nozik E, McKinsey TA, Faubel S. Female and male mice have differential longterm cardiorenal outcomes following a matched degree of ischemia-reperfusion acute kidney injury. Sci Rep. 2022 Jan 12;12(1):643. doi: 10.1038/s41598-021-04701-x. PMID: 35022484; PMCID: PMC8755805.
Copy Download .nbib Format: NLM
Showing 3757 to 3761 of 3761 entries